High initial (1, 3) Beta-d-Glucan concentration may be a predictor of satisfactory response of c aspofungin combined with TMP/SMZ for HIV-negative patients with moderate to severe Pneumocystis jirovecii pneumonia

卡斯波芬金 内科学 医学 甲氧苄啶 乳酸脱氢酶 耶氏肺孢子虫 联合疗法 胃肠病学 肺孢子虫肺炎 死亡率 肺炎 外科 氟康唑 抗真菌 生物 抗生素 微生物学 酶 生物化学 皮肤病科
作者
Fan Jin,Xiaohang Liu,Wen-can Chen,Zhangling Fan,Huanling Wang
出处
期刊:International Journal of Infectious Diseases [Elsevier BV]
卷期号:88: 141-148 被引量:33
标识
DOI:10.1016/j.ijid.2019.08.015
摘要

OBJECTIVES: The aim of this study was to investigate the efficacy of combination therapy of caspofungin and TMP/SMZ (trimethoprim/sulfamethoxazole) in moderate to severe pneumocystis jirovecii pneumonia (PJP) in patients without human immunodeficiency virus infection (HIV) and the relationship between therapeutic effect and plasma (1, 3) Beta-d-Glucan (BDG) levels. METHODS: We retrospectively reviewed HIV-negative patients with PJP diagnosed in our department, who were treated with combination therapy of caspofungin and TMP/SMZ or monotherapy of TMP/SMZ during a six and a half year period. RESULTS: A total of 126 moderate to severe PJP patients were enrolled in the study. In the multivariate analysis, low lymphocyte counts, high serum lactate dehydrogenase levels at the diagnosis of PJP and progression to shock were significant risk factors for death. In all patients, there was no significant difference in risk of death at 3 months. In the group of BDG≥800pg/m, patients receiving combination therapy was associated with a significantly decreased risk of death at 3 months, whereas in the group of BDG<800pg/ml, there were no statistically significant difference in survival rate between the two treatment regimens. CONCLUSION: High initial plasma (1, 3) Beta-d-Glucan concentration may be a predictor of satisfactory caspofungin response to HIV-negative patients with PJP. Based on our findings, we suggest the choice of combination therapy with caspofungin and TMP/SMZ as the initial treatment when BDG≥800pg/ml in moderate to severe HIV-negative patients with PJP.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
jy发布了新的文献求助10
1秒前
1秒前
2秒前
完美世界的应助被神奇宝贝采纳,获得10
2秒前
Moo完成签到 ,获得积分10
2秒前
共享精神的应助被大力的纸鹤采纳,获得10
3秒前
小饼干发布了新的文献求助10
3秒前
DUDUDUDU完成签到,获得积分10
3秒前
3秒前
4秒前
卡皮巴拉发布了新的文献求助10
4秒前
自觉飞飞发布了新的文献求助10
4秒前
l1995发布了新的文献求助10
4秒前
course完成签到 ,获得积分10
5秒前
5秒前
5秒前
5秒前
6秒前
林林林完成签到,获得积分10
6秒前
7秒前
机智的白卉的应助被xucc采纳,获得10
7秒前
华仔的应助被科研通管家采纳,获得10
7秒前
桐桐的应助被科研通管家采纳,获得10
7秒前
无极微光的应助被科研通管家采纳,获得20
7秒前
无极微光的应助被科研通管家采纳,获得20
7秒前
null的应助被科研通管家采纳,获得10
7秒前
CipherSage的应助被科研通管家采纳,获得10
7秒前
ding的应助被科研通管家采纳,获得10
8秒前
乐乐的应助被科研通管家采纳,获得30
8秒前
Ava的应助被科研通管家采纳,获得10
8秒前
Akim的应助被科研通管家采纳,获得10
8秒前
顾矜的应助被科研通管家采纳,获得10
8秒前
miemie阳完成签到,获得积分10
8秒前
8秒前
wefun的应助被科研通管家采纳,获得10
8秒前
Liang完成签到,获得积分10
8秒前
秋风的应助被科研通管家采纳,获得10
8秒前
9秒前
9秒前
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8161319
求助须知:如何正确求助?哪些是违规求助? 9556017
关于积分的说明 21731933
捐赠科研通 7751355
什么是DOI,文献DOI怎么找? 3427537
关于科研通互助平台的介绍 2552583
邀请新用户注册赠送积分活动 2471987